Overview

Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to evaluate whether treatment with a nasal spray based on resveratrol has some benefit in patients with seasonal allergic rhinitis, mild, moderate, or severe.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Second University of Naples
University of Campania "Luigi Vanvitelli"
Treatments:
Resveratrol
Criteria
Inclusion Criteria:

- Children of both sexes, ranging in age from 4 to 17 years

- History of seasonal allergic rhinitis, mild, moderate or severe, defined according to
the ARIA guidelines in 2010, documented by recurrent episodes in the previous year and
confirmed by a positive skin test results

- Written informed consent from at least one parent or a legal representative

Exclusion Criteria:

- Lack of informed consent in writing by at least one parent or a legal representative

- Concomitant disorders, such as infection of the upper (sinusitis, etc..) or lower
respiratory tract, nasal surgery in the last year, abnormalities of the respiratory
tract, immune diseases

- Use of antihistamines, nasal or systemic corticosteroids, leukotriene modifiers,
cromolyn sodium, in the last six weeks